Nanjing Vishee Medical Technology Stock Forecast for 2023 - 2025 - 2030
Updated on 09/27/2023
Nanjing Vishee Medical Technology Stock Forecast and Price Target
The average target price for Nanjing Vishee Medical Technology's stock set by renowned analysts in recent months is ¥75.23, representing a potential upside of approximately 100% from its last closing price if met by 2024. This estimation is based on a high estimate of ¥82.46 and a low estimate of ¥68.00.
0.00% Upside
Nanjing Vishee Medical Technology Fair Value Forecast for 2023 - 2025 - 2030
Nanjing Vishee Medical Technology's Price has decreased by 0.00% In the last year, from ¥33.00 to ¥33.00. In the following year, the 0 analysts surveyed believe that Nanjing Vishee Medical Technology's Fair Value will decrease by 0.00%, reaching ¥33.00. According to professionals, by 2030, Nanjing Vishee Medical Technology's Fair Value will have decreased by 0.00%, falling down to ¥33.00.
Nanjing Vishee Medical Technology Revenue Forecast for 2023 - 2025 - 2030
In the last year, Nanjing Vishee Medical Technology's Revenue has grown by 13.66%, from ¥378.37M to ¥430.04M. In the following year, the 0 analysts surveyed believe that Nanjing Vishee Medical Technology's Revenue will decrease by 12.02%, reaching ¥378.35M. According to professionals, by 2030, Nanjing Vishee Medical Technology's Revenue will have decreased by 7.30%, falling down to ¥398.65M.
Nanjing Vishee Medical Technology Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last year, Nanjing Vishee Medical Technology's Free Cash Flow has decreased by 35.82%, from ¥109.11M to ¥70.03M. For next year, analysts predict Free Cash Flow of ¥109.11M, which would mean an increase of 55.80%. Over the next nine years, experts predict that Nanjing Vishee Medical Technology's Free Cash Flow will grow at a rate of 46.94%.
Nanjing Vishee Medical Technology Net Income Forecast for 2023 - 2025 - 2030
In the last year, Nanjing Vishee Medical Technology's Net Income has grown by 23.77%, rising from ¥143.66M to ¥177.81M. According to the 0 analysts polled, in the next year, Nanjing Vishee Medical Technology's Net Income will fall by 19.21%, reaching ¥143.65M. By 2030, professionals believe that Nanjing Vishee Medical Technology's Net Income will have decreased by 11.02%, falling to ¥158.22M.
Nanjing Vishee Medical Technology EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Nanjing Vishee Medical Technology's EBITDA has grown, rising from ¥150.33M to ¥168.33M – a growth of 11.97%. According to 0 prominent analysts, Nanjing Vishee Medical Technology's EBITDA will fall by 10.69% in the next year, reaching ¥150.34M. By 2030, professionals believe that Nanjing Vishee Medical Technology's EBITDA will decrease by 6.56%, reaching ¥157.29M – a concerning trend for the company.
Nanjing Vishee Medical Technology EBIT Forecast for 2023 - 2025 - 2030
Nanjing Vishee Medical Technology's EBIT has grown In the last year, rising from ¥141.90M to ¥158.44M – a growth of 11.66%. In the following year, 0 experts forecast Nanjing Vishee Medical Technology's EBIT will decrease by 10.44%, to ¥141.90M. In 2030, professionals predict that Nanjing Vishee Medical Technology's EBIT will decrease by 6.41%, to ¥148.29M.
Nanjing Vishee Medical Technology EPS Price Prediction Forecast for 2023 - 2025 - 2030
Nanjing Vishee Medical Technology's EPS has decreased by 0.00% In the last year, from ¥2.20 to ¥2.20. In the following year, the 0 analysts surveyed believe that Nanjing Vishee Medical Technology's EPS will decrease by 0.00%, reaching ¥2.20. According to professionals, by 2030, Nanjing Vishee Medical Technology's EPS will have decreased by 0.00%, falling down to ¥2.20.